$DVA

$184.03 +$0.39 (0.21%) Close

$DVA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$DVA Management Team

Ms. Pamela Arway

Independent Chair of the Board

Age 71

Compensation $499.7K USD

Sex Female

Mr. Javier Rodriguez

Chief Executive Officer

Director

Age 54

Compensation $21.81M USD

Sex Male

Mr. James Hearty

Chief Compliance Officer

Age 56

Compensation $2.337M USD

Sex Male

Mr. David Maughan

Chief Operating Officer - Davita Kidney Care

Age 48

Compensation $4.933M USD

Sex Male

Mr. Joel Ackerman

Chief Financial Officer

Treasurer

Age 60

Compensation $6.350M USD

Sex Male

Mr. Christopher Berry

Chief Accounting Officer

Age 50

Compensation -

Sex Male

Ms. Kathleen Waters

Chief Legal and Public Affairs Officer

Age 57

Compensation $4.651M USD

Sex Female

Mr. Nic Eliason

IR Contact Officer

Age -

Compensation -

Sex Male

Ms. Stephanie Hendrickson

Chief People Officer

Age -

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Ms. Pamela Arway Independent Chair of the Board	71	$499.7K USD	Female
Mr. Javier Rodriguez Chief Executive Officer Director	54	$21.81M USD	Male
Mr. James Hearty Chief Compliance Officer	56	$2.337M USD	Male
Mr. David Maughan Chief Operating Officer - Davita Kidney Care	48	$4.933M USD	Male
Mr. Joel Ackerman Chief Financial Officer Treasurer	60	$6.350M USD	Male
Mr. Christopher Berry Chief Accounting Officer	50	-	Male
Ms. Kathleen Waters Chief Legal and Public Affairs Officer	57	$4.651M USD	Female
Mr. Nic Eliason IR Contact Officer	-	-	Male
Ms. Stephanie Hendrickson Chief People Officer	-	-	Female

Board of Directors

From the proxy statement filed Apr 22, 2026

Directors

serving now

Independent

8 of 9

stated in the proxy

Average tenure

7.0 years

from year joined

CEO also chairs the board

Pamela M. Arway

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Pamela M. Arway Board chair	72	2009 17 years	Independent	Compensation Committee Nominating and Governance Committee	Iron Mountain Inc.	$502,449
Barbara J. Desoer	73	2015 11 years	Independent	Compensation Committee · Chair Audit Committee	None stated	$389,949
Jason M. Hollar	53	2022 4 years	Independent	Audit Committee · Chair	Cardinal Health, Inc.(NYSE: CAH)	$377,449
Gregory J. Moore	61	2021 5 years	Independent	Compliance and Quality Committee · Chair Nominating and Governance Committee	Fortive Corporation (NYSE: FTV)	Not stated
Dennis W. Pullin	66	2024 2 years	Independent	Compliance and Quality Committee Nominating and Governance Committee	None stated	$322,449
Javier J. Rodriguez CEO	55	2019 7 years	Not independent	None stated	Gilead Sciences, Inc. (NASDAQ: GILD)	Paid as CEO
Adam H. Schechter	61	2022 4 years	Independent	Audit Committee Compensation Committee	Labcorp Holdings Inc. (NYSE: LH)	$337,449
Wendy L. Schoppert	59	2023 3 years	Independent	Audit Committee Compensation Committee	Fossil Group, Inc.(NASDAQ: FOSL)	$339,949
Phyllis R. Yale	68	2016 10 years	Independent	Nominating and Governance Committee · Chair Compliance and Quality Committee	Bristol-Myers Squibb Company (NYSE: BMY)	$379,949

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 22, 2026

Berkshire Hathaway Inc.

beneficial owner of more than 5% of the Company’s Common Stock

Amount not stated

Share repurchase agreement under which the Company repurchases shares of Common Stock from Berkshire quarterly to keep Berkshire's ownership at 45.0%, at the volume-weighted average price of the Company's program repurchases.

With the Company Open in proxy

Berkshire Hathaway Inc.

beneficial owner of more than 5% of the Company’s Common Stock

Approximately $485 million

2025

Company repurchased shares of Common Stock from Berkshire under the share repurchase agreement during 2025.

With the Company Open in proxy

Comments

Company Executives

$DVA Management Team

Ms. Pamela Arway

Mr. Javier Rodriguez

Mr. James Hearty

Mr. David Maughan

Mr. Joel Ackerman

Mr. Christopher Berry

Ms. Kathleen Waters

Mr. Nic Eliason

Ms. Stephanie Hendrickson

Board of Directors

Related-party transactions